Response to Comments: Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases

This document is an administrative response to comments on the draft LCD for Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases; it does not include clinical coverage criteria. The official notice period for the final LCD begins May 29, 2025, and the final determination becomes effective July 13, 2025; consult the final LCD after that date for indications, limitations, documentation, and frequency rules.

"This response to comments is administrative and does not itself constitute a coverage determination for genomic sequence analysis panels."

Sign up to see full coverage criteria, indications, and limitations.